ISTH 2022 Congress
Venous Thromboembolism
Theme Navigation
-
Abstract Number: VPB1381
A Case Series In Pregnant Women Receiving Therapeutic LMWH, Is Monitoring Anti-Xa Levels Necessary?
-
Abstract Number: OC 56.1
A Cross-Ancestry Meta-Analysis of Venous Thromboembolism Genetic Associations
-
Abstract Number: PB0933
A randomized clinical trial to evaluate the effect of rosuvastatin with enoxaparin on circulating tissue factor extracellular vesicles following ovarian cancer surgery
-
Abstract Number: VPB1378
A systematic review of factors associated with non-adherence to the use of coumarin derivatives or direct oral anticoagulants
-
Abstract Number: PB1322
A ten-year Australian experience of splanchnic vein thrombosis
-
Abstract Number: OC 48.2
A TEN-YEAR REVIEW OF THE IMPACT OF TRANSITION FROM WARFARIN TO DIRECT ORAL ANTICOAGULANT– HAS VTE TREATMENT BECOME SAFER?
-
Abstract Number: PB1365
A Tool Integrated in the Electronic Health Record to Guide Proper Decision-Making Regarding Peri-Endoscopic Anticoagulant Use
-
Abstract Number: PB0927
Abelacimab does not influence the effects of two commonly used antiplatelet agents in vitro
-
Abstract Number: PB0925
Abelacimab has no effect on platelet aggregation induced by TRAP-6 and collagen
-
Abstract Number: VPB1344
ABO blood group and factor viii level as risk factors for idiopathic venous thromboembolism.
-
Abstract Number: VPB1314
ABO blood group as an additional risk factor for venous thromboembolism
-
Abstract Number: PB0447
Adherence and persistence to Direct Oral Anticoagulants (DOACs) in the community following newly diagnosed Venous Thromboembolism (VTE) – a pharmacy-linkage study
-
Abstract Number: PB0960
Adherence to thrombophilia testing guidelines and accuracy of thrombophilia work-up: a single-center cross sectional study
-
Abstract Number: PB0972
Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial
-
Abstract Number: VPB1342
Aetiological profile of inferior veina cava thrombosis
-
Abstract Number: OC 32.3
Anti-β2-glycoprotein I antibodies cause activated protein C resistance by interfering with Factor V cleavage at Arginine 506
-
Abstract Number: VPB0944
Anticoagulant associated bleeding risk assessment model for cancer associated thrombosis patients: A systematic review
-
Abstract Number: PB0431
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
-
Abstract Number: PB1370
Anticoagulation Control, Outcomes and Associated Factors in Patients Receiving Warfarin in Long-term care in Africa: A Systematic Review
-
Abstract Number: PB0414
Antiphospholipid Syndrome-related Venous Thromboembolism: A Nationwide Study
- 1
- 2
- 3
- …
- 15
- Next Page »